author-photo

Krystin Bedard

University of Massachusetts Medical School

3

Papers

263

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss

2010 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (41)
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.

2010 Oncogene
Show All
- Source
- Cite
- Save
Citations (221)
Runx2 in breast and prostate cancer cells: Roles in adhesion, invasion and tumor activity in bone

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)